Current Opportunities and Challenges of Magnetic Resonance Spectroscopy, Positron Emission Tomography, and Mass Spectrometry Imaging for Mapping Cancer Metabolism In Vivo
Cancer is known to have unique metabolic features such as Warburg effect. Current cancer therapy has moved forward from cytotoxic treatment to personalized, targeted therapies, with some that could lead to specific metabolic changes, potentially monitored by imaging methods. In this paper we address...
Main Authors: | Gigin Lin, Yuen-Li Chung |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2014/625095 |
Similar Items
-
Magnetic Resonance Spectroscopy, Positron Emission Tomography and Radiogenomics—Relevance to Glioma
by: Gloria C. Chiang, et al.
Published: (2018-02-01) -
Quantitative accuracy of positron emission tomography/magnetic resonance and positron emission tomography/computed tomography for cervical cancer
by: Jorge Daniel Oldan, et al.
Published: (2018-01-01) -
Manganese imaging with positron emission tomography, autoradiography, and magnetic resonance
by: Topping, Geoffrey John
Published: (2014) -
Manganese imaging with positron emission tomography, autoradiography, and magnetic resonance
by: Topping, Geoffrey John
Published: (2014) -
Liquid chromatography-mass spectrometry in the analysis of radiolabelled compounds for positron emission tomography
by: Hyllbrant Forngren, Benita
Published: (2000)